Virtual Library

Start Your Search

  • TTLC 2021

    Targeted Therapies in Lung Cancer 2021

    Access to all slides from presentations that occur during the IASLC 2021 Targeted Therapies of Lung Cancer Meeting

    Presentation Date(s):  
    • February 17 - 20, 2021
    • Total Presentations: 76

Filter Results:

Show Only Available Presentations

  • +

    P11 - Therapy for Early Stage

    • Type: Poster
    • Track:
    • Presentations: 2
    • Presentations Available
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      Correlation Between Histological Subtypes and Prognosis in Patients With Early Stage Lung Adenocarcinoma: An Observational Retrospective Cohort Study (Presentation Available)

      00:00 - 00:00  |  Author(s): Stylianos Gaitanakis

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Expressions of Biomarkers of Malignant Pleural Mesothelioma at Pham Ngoc Thach Hospital, Vietnam in 5 Years From 2015-2019 (Presentation Available)

      00:00 - 00:00  |  Author(s): Nguyen Son Lam

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    S01 - Early Career/Young Investigator Session (Sign Up Required)

    • Type: General Session
    • Track:
    • Presentations: 6
    • Presentations Available
    • Coordinates: 2/17/2021, 15:45 - 16:45,
  • +

    S02 - Welcome & Opening Keynote

    • Type: General Session
    • Track:
    • Presentations: 1
    • Presentations Available
    • Coordinates: 2/17/2021, 17:00 - 18:00,
  • +

    S03 - Targeted Therapies - EGFR

    • Type: General Session
    • Track:
    • Presentations: 4
    • Presentations Available
    • Coordinates: 2/18/2021, 13:30 - 14:30,
  • +

    S04 - Targeted Therapies - ALK & ROS1 Inhibitors

    • Type: General Session
    • Track:
    • Presentations: 4
    • Presentations Available
    • Coordinates: 2/18/2021, 14:40 - 15:40,
    • +

      New Studies of Approved Agents: Crizotinib, Ceritinib, Alectinib, Lorlatinib, Ensartinib - New Data and Resistance Mechanisms; Brigatinib (Presentation Available)

      14:40 - 14:50  |  Author(s): Ignatius (Sai-Hong) Ou

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      New Agents Not Yet Approved: Repotectinib, DS6051b, TPX-0131 (Presentation Available)

      14:50 - 15:00  |  Author(s): Jessica Lin

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Combinations: VEGF, Trametinib, CDK4/6, mTOR (Presentation Available)

      15:00 - 15:10  |  Author(s): Shirish Gadgeel

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Continuing TKI Beyond Progression (All Drivers- RET, MET, EGFR, etc.) (Presentation Available)

      15:10 - 15:20  |  Author(s): Ross Camidge

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    S05 - Targeted Therapies - KRAS

    • Type: General Session
    • Track:
    • Presentations: 4
    • Presentations Available
    • Coordinates: 2/18/2021, 15:50 - 16:50,
  • +

    S06 - Targeted Therapies - All The Others

    • Type: General Session
    • Track:
    • Presentations: 4
    • Presentations Available
    • Coordinates: 2/18/2021, 17:00 - 18:00,
  • +

    S07 - Immunotherapy- IO and other Novel Combinations

    • Type: General Session
    • Track:
    • Presentations: 4
    • Presentations Available
    • Coordinates: 2/19/2021, 13:30 - 14:30,
  • +

    S08 - Immunotherapy - Biomarkers

    • Type: General Session
    • Track:
    • Presentations: 4
    • Presentations Available
    • Coordinates: 2/19/2021, 14:40 - 15:40,
  • +

    S09 - Immunotherapy - Other Immunologic

    • Type: General Session
    • Track:
    • Presentations: 4
    • Presentations Available
    • Coordinates: 2/19/2021, 15:50 - 16:50,